New DCAT Member Company Alert
By

By
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view…

New Episode: Production to Prescription Podcast: 2025: The Bio/Pharma Industry’s Year in Review
By

By
Without question, evolving US tariff and trade policy was the story of the year in 2025, and how such policy will be implemented looms large. At the same time, the…

ICYMI: 2026 DCAT Value Chain Insights Editorial Calendar Now Available
By

By
In case you missed it, the 2026 DCAT Value Chain Insights Editorial Calendar is now available.  The feature schedule for 2026 focuses on major themes impacting the business of bio/pharmaceutical…

ESG Update: DCAT Member Companies in the Community 
By

By
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…

ICYMI: Production to Prescription Podcast: Drug Launches & Approvals in 2025: The Blockbuster Contenders 
By

By
Each year, the promise of new market entries loom in the bio/pharmaceutical industry. Which products, launched or approved thus far in 2025, may be potential blockbusters (defined as drugs with sales of $1…

Unwind and Network With Us at DCAT After the Show in Frankfurt 
By

By
Are you attending the show in Frankfurt? Don’t miss DCAT After the Show on Wednesday, October 29, at 7:00 – 9:30 PM, an exclusive networking experience for employees of DCAT Member Companies.  After a busy…

ESG Update: DCAT Member Companies in the Community
By

By
The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities.  Have a ESG news announcement…

People on the Move
By

By
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…

ICYMI: DCAT Production to Prescription Podcast: “Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?” 
By

By
Biotech companies are an important source for innovation and product development for larger companies and are an important customer base of CDMOs/CMOs. Capital flow in the biotech sector, a key…

DCAT Awards Grants To Student Scientists at the 2025 Regeneron International Science & Engineering Fair  
By

By
The Drug, Chemical & Associated Technologies Association (DCAT) has awarded $30,000 in grants to student scientists of four projects who participated in the Regeneron International Science & Engineering Fair (Regeneron…